Jeffrey S. Hatfield's Net Worth

$8.34 Million

Estimate Recalculated Nov 8, 2024 04:40PM EST

Who is Jeffrey S. Hatfield?

Jeffrey S. Hatfield has an estimated net worth of $8.34 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., Vir Biotechnology, Inc., ZAFGEN, INC., INVIVO THERAPEUTICS HOLDINGS CORP., aTYR PHARMA INC, Vitae Pharmaceuticals, Inc, and AMBIT BIOSCIENCES CORP.

SEC CIK

Jeffrey S. Hatfield's CIK is 0001609879

Past Insider Trading and Trends

2015 was Jeffrey S. Hatfield's most active year for acquiring shares with 8 total transactions. Jeffrey S. Hatfield's most active month to acquire stocks was the month of April. 2016 was Jeffrey S. Hatfield's most active year for disposing of shares, totalling 12 transactions. Jeffrey S. Hatfield's most active month to dispose stocks was the month of September. 2015 saw Jeffrey S. Hatfield paying a total of $315,106.90 for 172,810 shares, this is the most they've acquired in one year. In 2016 Jeffrey S. Hatfield cashed out on 743,732 shares for a total of $12,100,058.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $14.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Jun 27
Form 3
—
0
—
—
0
No matching records found

Vir Biotechnology, Inc. (VIR) Snapshot price: $7.63

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.61%
8K
—
—
23.81K
May 30
Form 4
+61.63%
6.03K
—
—
15.81K
May 22
Form 4
+189.83%
6.41K
—
—
9.78K
May 23
Form 4
∞
3.37K
—
—
3.37K
May 21
Form 4
—
0
—
—
0
Dec 9
Form 3
—
0
—
—
0
No matching records found

ZAFGEN, INC. (LRMR) Snapshot price: $8.05

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Dec 29
Form 4
—
0
—
—
0
Oct 9
Form 3
—
0
—
—
0
No matching records found

INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Nov 1
Form 3
—
0
—
—
0
No matching records found

aTYR PHARMA INC (LIFE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 9
Form 4
—
0
—
—
0
Apr 3
Form 3
—
0
—
—
0
No matching records found